These sessions are organized by industry partners and are separate from the official NordCoag 2026 scientific programme. Each session is limited to 25 participants. Registration links will be made available before the congress begins.
Day 1 – Wednesday, 16 September 2026
12:30 – 13:15
Novo Nordisk / Novel Treatment Strategies and Perioperative Management in Haemophilia B
12:30-12:35 Welcome and introduction / Moderator TBD
12:35-12:45 Unmet needs in Haemophilia B and rationale for novel therapies / Víctor Jiménez-Yuste*, Madrid, Spain
12:45-13:05 Anti‑TFPI treatments in Haemophilia B: opportunities and challenges / Víctor Jiménez-Yuste*, Madrid, Spain
13:05-13:15 Case presentations and interactive discussion / Moderator TBD
*Professor at Universidad Autónoma de Madrid, Spain
Takeda / Von Willebrand Disease throughout life
12:30-12:35 Welcome and introduction / Moderator Jan Astermark*, Malmö, Sweden
12:35-12:45 Von Willebrand Disease in Children: Early recognition and Practical Management / Tony Frisk, Stockholm, Sweden
12:45-13:05 Von Willebrand Disease in Adults: Practical Management and Long-Term care / Ritta Lassila**, Helsinki, Finland
13:05-13:15 Moderated discussion and Q&A / Moderator Jan Astermark, Malmö, Sweden
*Professor, Manager of Coagulation Unit, Skåne University Hospital Malmö / Head of Department, Translational Medicine, Lund University, Sweden
**Professor of Coagulation Medicine, University of Helsinki, Finland
Day 2 – Thursday, 17 September 2026
08:00 – 08:45
Pfizer/ From Trial to Treatment Centre: Marstacimab OLE Updates and Practical Insights from the Clinic
08.00-08.05 Welcome and introduction / Moderator Maria Bruzelius
08.05-08.20 Presentation BASIS OLE study marstacimab / Ana Boban*, Zagreb, Croatia
08.20-08.35 Patient cases and treatment experience with Hympavzi (marstacimab)/ Florian Lange**, Hamburg, Germany
08.35-08.45 Discussion and closing remarks / Moderator Maria Bruzelius
* Professor, Head of the Haemophilia Centre, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Croatia
** Professor, Haemostasis Unit, Department of Internal Medicine II University, Medical Center Hamburg‑Eppendorf, Hamburg, Germany
12:20 – 13:05
Roche/TBD
Sobi/TBD
Day 3 – Thursday, 18 September 2026
08:00 – 08:45
Bayer/TBD
